Title | Combination Therapies 2 [electronic resource] : Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases / edited by Enrico Garaci, Allan L. Goldstein |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 1993 |
Connect to | http://dx.doi.org/10.1007/978-1-4615-2964-4 |
Descript | X, 256 p. online resource |
Section I - Mechanism of Action and Rationale for the Use of Biological Response Modifiers, Differentiating Agents and Nucleoside Analogues in Combination -- 1. Cytokine Synergy in Immunotherapy -- 2. Monitoring Combination Therapy Trials: New Challenges for the Clinical Laboratory -- 3. IL-2-Based Consolidative Immunotherapy After Autologous Bone Marrow Transplantation -- 4. Tumor Immunogenicity Induced by the Local. Occurrence of IL-2 -- 5. Thymosin ?1: Chemistry, Mechanism of Action and Clinical Applications -- 6. Combination Therapy with Thymosin ?1 and Cytokines in the Treatment of Cancer and Infectious Diseases -- 7. Effect of Thymosin a1 on Cocaine-induced Inhibition of T-Cell Dependent Murine Immune Response -- 8. Regulation of Gene Expression by Interferons -- 9. Interactions Between Tumor Necrosis Factor Alpha and Glucocorticoid Hormones in the Regulation of Tumor Cell Growth In Vitro -- 10. Behavioural, Pyrogenic and Electrocortical Effects of Tumor Necrosis Factor-Alpha Given Intracerebrally in Rats -- 11. Biological Significance and Therapeutic Potential of Tumor-Associated Leukocytes -- 12. Septic Shock Pathophysiology: Focus on Therapeutic Approach -- 13. Differentiating Agents and Cancer Therapy. Role of Cellular Lipid Peroxidation and its Product 4-Hydroxynonenal in the Control of Cell Proliferation and Differentiation -- 14. Inhibition of HIV Replication and Enhancement of Immune Functions by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonyl-Methoxyethyl) Adenine (PMEA) -- 15. Modulation of Inflammatory Cytokines by a Receptor Antagonist, Autoantibodies, and Fever -- Section II - Combination Chemotherapy and Brm Therapy in the Treatment of Cancer -- 16. Cancer Immunochemotherapy: Preliminary Studies with Triazene Compounds -- 17. Thymosin ?1 and ?-Interferon with Cisplatin and Etoposide in Advanced Non-Small Cell Lung Cancer: A Phase II Study -- 18. Combination of Chronic Indomethacin and Intermittent IL-2 Therapy in the Treatment of Disseminated Cancer -- 19. Combination Chemotherapy and Cytokines in the Treatment of Advanced Primary Lung Cancer: Results of a Controlled Clinical Trial -- 20. Biological Response Modifiers and Differentiating Agents in Myelodisplastic Syndromes -- 21. Myeloid Growth Factors in Cancer Treatment -- Section III - Single and Combination Therapy with Brmโs in the Treatment of Infectious Diseases, AIDS and Autoimmunity -- 22. Efficacy of the Combined Treatment with Fluconazole and Thymosin ?1 Against Candida albicans Infection in Morphine-Treated Mice -- 23. Anti-Cytokine Therapy of Murine Candidiasis -- 24. The Basic Research and Clinical Application of Thymopeptidin -- 25. Treatment of Hepatitis C Virus-Associated Chronic Liver Disease with ?-Interferon and Inosine Pranobex: Combination Schedule vs. Monotherapies -- 26. Sustained Response to Thymosin Therapy in Patients with Chronic Active Hepatitis B -- 27. Combination Anti-HIV Therapy: Questions and Answers -- 28. Mechanisms of Disease Progression and CD4 Depletion in HIV-1 Infection -- 29. Combined Therapy with Zidovudine, Thymosin ?l and ?-Interferon in the Treatment of HIV-Infected Patients -- 30. The Problem of Interferon Species Appearing in Patients with Autoimmune Diseases